Engineered Nano-Platelets for Enhanced Treatment of Multiple Myeloma and Thrombus

A platelet membrane-coated biomimetic nanocarrier, which could sequentially target bone microenvironment and myeloma cells to enhance the drug availability at the myeloma site and decrease the off-target effects, was developed for inhibiting the multiple myeloma growth and simultaneously eradicating the thrombus complication.